bluebird bio Market Cap

bluebird bio has a market cap or net worth of 60.62 million as of January 31, 2025. Its market cap has decreased by -71.75% in one year.

Market Cap

60.62M

Enterprise Value

305.55M

Revenue

39.63M

Ranking

n/a

PE Ratio

n/a

Stock Price

8.02

Market Cap Chart

Since June 19, 2013, bluebird bio's market cap has decreased from 392.09M to 60.62M, a decrease of -84.54%. That is a compound annual growth rate of -14.83%.

Market Cap History

Date	Market Cap	% Change
Jan 31, 2025	60.62M	-6.41%
Dec 31, 2024	64.77M	-68.98%
Dec 29, 2023	208.82M	-56.15%
Dec 30, 2022	476.17M	-7.94%
Dec 31, 2021	517.24M	-75.41%
Dec 31, 2020	2.10B	-42.62%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	175.89B
GSK plc	57.33B
Haleon	33.92B
Smith & Nephew	9.00B
Hikma Pharmaceuticals	5.08B
ConvaTec Group	5.06B
HUTCHMED (China)	1.88B
Oxford Nanopore Technologies	1.39B

Market Cap Rankings